Status:

RECRUITING

M-ARS ACL Post-marketing Surveillance Study

Lead Sponsor:

Medacta International SA

Conditions:

Anterior Cruciate Ligament (ACL) Reconstruction

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction. The main goal is to evaluate th...

Detailed Description

This s a prospective, multicenter, non-controlled, observational study to evaluate the outcomes of Medacta Anatomic Ribbon Surgery (M-ARS) in the reconstruction of the anterior cruciate ligament (ACL)...

Eligibility Criteria

Inclusion

  • Patients older than 18 years
  • Patients with ACL rupture requiring ACL reconstruction

Exclusion

  • Patients with malignant diseases (at the time of surgery)
  • Patients with proven or suspected infections (at the time of surgery)
  • Patients with functional deficits of the affected extremity (at the time of surgery)
  • Patients with known incompatibility or allergy to products materials (at the time of surgery)

Key Trial Info

Start Date :

July 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04462458

Start Date

July 1 2022

End Date

January 1 2027

Last Update

March 13 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Praxis Gelenkpunkt - Sport- und Gelenkchirurgie

Innsbruck, Austria, 6020

2

Pyhrn-Eisenwurzen Klinikum Kirchdorf

Kirchdorf an der Krems, Austria, 4560

3

OCM Klinik GmbH

München, Germany, 81369

M-ARS ACL Post-marketing Surveillance Study | DecenTrialz